Dr Rhiannon Mellor

Selected publications

2025
EBioMedicine10.1016/j.ebiom.2025.106058
Characterising the effect of circulating sphingolipids on metastatic prostate cancer cells.
Neil Portman, Blossom Mak, Nicole Yeung, Hui-Ming Lin, Rachel M N Kim, Rhiannon Mellor, Luke Ardolino, Diana Gutierrez, Martina Raneri, Tahlia Scheinberg, David J Handelsman, Tania Moujaber, Peter J Meikle, Kevin Huynh, Anthony M Joshua, Andrew J Hoy, Lisa Butler, Lisa G Horvath
2025
Therapeutic Advances in Medical Oncology10.1177/17588359251347857
Immunotherapy in metastatic prostate cancer.
Liam Dwyer, Claudia Leslie, Rhiannon Mellor, Tahlia Scheinberg, Renea A Taylor, Lisa G Horvath
2024
Therapeutic Advances in Medical Oncology10.1177/17588359241307814
Evolocumab in metastatic castration-resistant prostate cancer: study protocol for a single-arm, phase II trial, and initial experience with use of a validated lipid biomarker to direct therapy.
Rhiannon Mellor, Luke Ardolino, Tahlia Scheinberg, Michael Fitzpatrick, Hui-Ming Lin, Paul Bonnitcha, David Sullivan, Peter J Meikle, Martin R Stockler, Tania Moujaber, Anthony Joshua, Lisa Horvath
2024
Internal Medicine Journal10.1111/imj.16574
Final results of the National Oncology Mentorship Program 2023 and its impact on burnout and professional fulfilment.
Udit Nindra, Gowri Shivasabesan, Rhiannon Mellor, Weng Ng, Wei Chua, Deme Karikios, Bethan Richards, Jia Liu